Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
Authors:
- Michael O. SweeneyMSMichael O. Sweeney
- for the MOST InvestigatorsFIfor the MOST Investigators
- 20 February 2004
- journal article
- clinical trial
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 15 (2) , 153-160
Abstract
Introduction:Atrial fibrillation (AF) is common in pacemaker patients with sinus node dysfunction (SND) and may result in rapid ventricular pacing (RVP) in the DDDR mode. Mode switching (MS) reduces RVP, but its clinical benefit in patients with SND is unknown.Methods and Results:Two hundred two patients in the Mode Selection Trial (MOST; 2,010‐patient, 6‐year trial of DDDR vs VVIR pacing in SND) randomized to DDDR pacemakers with atrial high‐rate episode (AHRE) storage capabilities were subrandomized to MS ON (N = 96) or MS OFF (N = 106). Cardiovascular symptoms, quality of life (QOL), reprogramming due to RVP, death, stroke, and heart failure hospitalization (HFH) were compared between groups. The treatment groups were similar with regard to AF history (59% MS ON vs 57% MS OFF). AHREs occurred in 49% patients during median follow‐up of 2.2 years. Median AHRE duration (in min; MS ON 116 vs MS OFF 58, P = 0.29), frequency AHREs/week (MS ON 3.5 vs MS OFF 6.4, P = 0.23), and time spent in AHRE (min/week) (MS ON 450, MS OFF 268) were similar. Reprogramming due to any RVP during AHREs occurred more in MS OFF vs MS ON (13.2% vs 3.1%, P = 0.011) and marginally more for symptomatic RVP (8.5% vs 2.1%, P = 0.062). Cardiovascular symptoms occurred in 93.6% MS ON vs 90.2% MS OFF (P = 0.38). Median number of symptoms reported per visit was similar (MS ON 1.3 vs MS OFF 1.5, P = 0.62). Median symptom frequency/severity, summed and averaged over visits, was similar (MS ON 4.3 vs MS OFF 4.5, P = 0.74). QOL was not different between groups. Death, stroke, and HFH were not different between groups.Conclusion:MS reduces pacemaker reprogramming due to RVP during AHREs in a small number of patients but does not improve QOL or cardiovascular symptoms overall among patients with SND.(J Cardiovasc Electrophysiol, Vol. 15, pp. 153‐160, February 2004)Keywords
This publication has 47 references indexed in Scilit:
- Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node DysfunctionNew England Journal of Medicine, 2002
- Atrial Fibrillation After DDDR Pacemaker ImplantationJournal of Cardiovascular Electrophysiology, 2002
- Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular CausesNew England Journal of Medicine, 2000
- Survival of DDD pacing mode after atrioventricular junction ablation and pacing for refractory atrial fibrillationAmerican Heart Journal, 1999
- Mode switching in dual chamber pacemakersEP Europace, 1999
- Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillationHeart, 1998
- Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber PacingNew England Journal of Medicine, 1998
- LETTERS TO THE EDITORPacing and Clinical Electrophysiology, 1997
- Evaluation of a New Pacing Algorithm to Prevent Rapid Tracking of Atrial TachyarrhythmiasPacing and Clinical Electrophysiology, 1996
- Dual chamber pacing: how many patients remain in DDD mode over the long term?Heart, 1995